Cancer Vaccine Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, vaccine, more »


 
1-10 of about 100 reports for Cancer Vaccine

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Asset transactions 32expres2ion biotech acquires ip rights related to recombinant protein production technology from affitech 32affitech completes sale of its remaining rights of cancer vaccine to gemvax 33 ...

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... And treatment of cancer and viral infections for the research and design of anti-viral and anti cancer vaccines. Altor is headquartered in miramar, florida, the us.Altor bioscience corporation ...

Serum Institute of India Limited - Product Pipeline Review - 2014

Serum Institute of India Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

... R&d progress 24bladder cancer vaccine 25product description 25mechanism of action 25r&d progress 25pneumococcal polysaccharide conjugate vaccine 26product description 26 ...

DNA Vaccines: Technologies and Global Markets

DNA Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

... Emerging competitive landscape for dna vaccines 31cancer dna vaccines 31table 15 cancer vaccine types 32dna vaccine technology value chain 33figure 5 dna vaccine technology value chain 33 ...

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Neu breast cancer vaccine approach has the potential to treat 85% of her2/neu breast cancer patients. Its polystart vaccine is used to treat oncology and infectious diseases. The company's product ...

Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... cancer vaccines drug pipeline update 2014 cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite ...

Biovest International, Inc. (BVTIQ) - Financial and Strategic SWOT Analysis Review

Biovest International, Inc. (BVTIQ) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... Are focused on developing biovaxid and potentially other b-cell blood cancer vaccines; manufacturing and sale of autovaxid and other instruments and consumables; and commercial production of cell culture ...

Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • June 2014
  • by Currentpartnering

... Biotech infectious vaccines deal frequency - 2007 to 2013figure 6: active cancer vaccine dealmaking activity- 2007 to 2013figure 7: infectious vaccines partnering by deal type since 2007figure 8 ...

Kidney Cancer Treatment Drugs Markets in China

Kidney Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • June 2014
  • by Asia Market Information & Development Company

... Major producer facility locations major producer sales volume and market share alkylating agents antimetabolites anti-tumor antibiotics steroids cytokines cancer ...

Skin Cancer Treatment Drugs Markets in China

Skin Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • June 2014
  • by Asia Market Information & Development Company

... Facility locationsmajor producer sales volume and market share fluorouracil bleomycin cisplatin mitomycin retinoids -Interferon interleukin cancer ...

About 400 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Disease State Primer: Ovarian Cancer
  • January 2012
    8 pages
  • Ovarian Cancer  

    Cancer  

  • United States  

    World  

    North America  

View report >

1 Companies for Cancer Vaccine

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.